| Market Cap | 58 | P/E | - | EPS this Y | - | Ern Qtrly Grth | -69.40% |
| Income | 16.64k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -100.00% |
| Sales | 1.07M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -100.00% |
| Dividend | N/A | Price/Book | 0.00 | EPS next 5Y | - | 52W High Chg | -100.00% |
| Recommedations | - | Quick Ratio | 2.92 | Shares Outstanding | 164.49K | 52W Low Chg | - |
| Insider Own | - | ROA | - | Shares Float | - | Beta | 3.24 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00000 |
| Gross Margin | 57.84% | Profit Margin | 1.56% | Avg. Volume | 149,856 | Target Price | - |
| Oper. Margin | 65.49% | Earnings Date | - | Volume | 30,000 | Change | 0.00% |
Dazed, Inc. focuses on retail, distribution, hospitality, licensing, and franchising of portfolio of counterculture brands. The company was formerly known as MedX Holdings, Inc. and changed its name to Dazed, Inc. in October 2022. Dazed, Inc. was founded in 2004 and is based in Cheyenne, Wyoming.
